Michael H. A. Roehrl

Sloan-Kettering Inst Can Research

$6,530,724

Attributed

$6,530,724

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY2019–25

$2M$1.5M$1M$500K$0

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$6,530,724 · 4

By mechanism

P30$4,565,337 · 1

U01$1,028,490 · 1

R21$936,897 · 2

Top collaborators

No co-investigators on record.

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Samuel Singer$8,089,401
Jason S Lewis$26,024,327
Jessica Scott$10,593,887
Margaret A Leversha$1,844,343
Andrea Cercek$4,410,417

Others in their field

Other Emerging Leaders on “Tumor”

Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213

Research focus

TumorMalignant NeoplasmsTissuesImmunohistochemistryMolecularProteinsSpecimenSamplingProtocols DocumentationProceduresFormalinNeoplastic CellFreezingBiobankHistologyBaseProteogenomicsCharacteristicsExperimental StudyMemorial Sloan-Kettering Cancer CenterCohortInnovationLengthCells